Chargement en cours...
Glioblastoma—a moving target
The slow development of effective treatment of glioblastoma is contrasted by the rapidly advancing research on the molecular mechanisms underlying the disease. Amplification and overexpression of receptor tyrosine kinases, particularly EGFR and PDGFRA, are complemented by mutations in the PI3K, RB1,...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Informa Healthcare
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3339557/ https://ncbi.nlm.nih.gov/pubmed/22512247 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/03009734.2012.676574 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|